Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Christopher Yea, officer

Transaction date: Feb. 21, 2026

Reporting date: Feb. 24, 2026

Average share price: -26.767753006329112

Sold 2528.0 shares for 67668.88